RALXFEM

ਉਤਪਾਦ ਝਲਕ

About RALXFEM

RALXFEM is a medication containing the active ingredient raloxifen, classified as Selective estrogen receptor modulator. Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. For osteoporosis it is less preferred than bisphosphonates. It is also used to reduce the risk of breast cancer in those at high risk.

Key Benefits & Uses

• Used for: Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those.
• Used for: For osteoporosis it is less preferred than bisphosphonates
• Used for: It is also used to reduce the risk of breast cancer in those at high risk

Active Ingredient & Action

raloxifen, the active ingredient in RALXFEM, belongs to the Selective estrogen receptor modulator class. Its clinical use follows the authorised labelling for raloxifen-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking RALXFEM. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use RALXFEM for extended periods without medical advice.